Men and women affected by cancer look for information about the disease in very different ways, a study of internet postings about prostate cancer and breast cancer patients and partners suggests.

While men seek medical-scientific and practical advice, women look for emotional support. Men concerned about prostate cancer were interested in cancer tests, symptoms, the latest treatments and side effects. Women concerned about breast cancer sought emotional and social support. They were eager to share their personal experience and the impact of their cancer on family and relationships.
(full story…)

RICHMOND, Va., April 12 /PRNewswire/ — Selenium levels may predict the
risk of a man’s prostate cancer, and now a simple, reliable selenium
test is available.

The first selenium test that predicts prostate cancer risk, SeleniumHealth(TM), is now available exclusively from Bostwick Laboratories, Inc., an international diagnostic pathology laboratory. A man simply trims one or more toenails and submits the clippings for selenium content. SeleniumHealth(TM) is provided by Bostwick Laboratories, Inc. under license from the Gerald P. Murphy Cancer Foundation.

Press release at: http://www.psa-rising.com/wiredbird/bostwick_selenium_0406.html